Histological classification of lung cancer
In 1924, when lung cancer was an uncommon disease, Marchesani proposed a classification of lung cancer into four histological groups. This was later expanded in the World Health Organisation's histological classification of lung tumours of 1967.' Further modification was found necessary and a second edition was produced by the WHO in 1981.2 This includes, under the heading "Malignant epithelial tumours," eight major groups, 12 variants or subtypes, and additional recommended subgroups based on the degree of differentation. Whimster in a volume reviewed on page 178 of this issue refers to some 70 tumours or tumour like conditions which have been reported as occurring in the lungs or pleura. 3 How can we reconcile such apparent pathological complexity with the need for a histological classification of lung tumours appropriate for day to day clinical practice? Most clinicians and some pathologists ignore the extended pathological classifications and manage with a condensed version of four headings: squamous carcinoma, adenocarcinoma, small cell undifferentiated carcinoma, and large cell undifferentiated carcinoma without further subdivision-shades of Marchesani. Such a shorthand summary of lung cancer classification is valuable for day to day discussion but is it valid as a serious classification given the complexity of the latest WHO classification? Is there evidence that the numerous subtypes detailed in this classification have any clinical significance?
There are some features in the natural history of tumours which appear to be related to their histological type. The rapid growth and early metastasis of small cell carcinoma is well recognised. Squamous carcinomas tend to grow slowly and metastasise late and a large proportion have not extended beyond the thorax at the time of death, whereas adenocarcinomas and large cell undifferentiated carcinomas fall in between these two extremes. Apart from the quite large variation in the proportions of lung cancer allocated to histological subgroups by the design of the classification, there is the problem of how accurately tumours are allocated to the different groups by different pathologists. The reproducibility of a classification is largely dependent on the quality and specificity of the criteria provided and the willingness of pathologists to apply them. Regrettably, this aspect of lung cancer classification leaves much room for improvement. In particular, there is little guidance in the "grey areas," where there may be histological doubt between two similar groups of tumours-for example, between poorly differentiated squamous carcinoma and large cell undifferentiated carcinoma. This lack of specific criteria allows different pathologists to interpret the guidelines differently.
Individual pathologists may show good reproducibility in their use of a classification, but when more than one pathologist is concerned the interobserver variation becomes a problem.'0 17 18 We may get some idea of the size of the problem by considering the diagnosis of small cell carcinoma, believed by many to be simple and reproducible. In a recent review of over 850 lung tumours coming to thoracotomy from 1968 to 1972 we reviewed the histological material from all cases originally diagnosed by several pathologists and identified 123 cases of small cell carcinoma.'9 To come to the final total of 123 small cell cases we had to change the original diagnosis from large cell to small cell in 13 cases and from small cell to large cell in eight. This gives a figure for the "grey area" between small cell carcinoma and large cell undifferentiated of some 17%. In addition, five examples of atypical carcinoid tumour had to be removed from the small cell carcinoma group.'9 The problem is greater in the case of carcinomas other than small cell, particularly when classification is based on fibreoptic bronchoscopic biopsy. Chuang et al, comparing preoperative fibreoptic biopsy cell typing with the final diagnosis based on the resected specimen, found that 38% of the patients undergoing resection had incorrect preoperative cell typing and that only three of 24 large cell undifferentiated carcinomas were confirmed after surgery20 (p 175 of this issue).
In the two WHO classifications the small cell carcinomas are subdivided into three subgroups. Hirsch et al'°investigated the interobserver variation in the diagnosis of small cell carcinoma and of the subtypes. The main diagnosis of small cell carcinoma was agreed by all three pathologists in just over 90% of cases, but in the diagnosis of the morphological subtypes unanimity between the three pathologists was achieved in only 38% of cases There are problems in the histological classification of lung tumours. The aim should surely be-at least nationally, and under ideal conditions internationally-to develop the use of a common classification with defined histological criteria and with sufficient knowledge of intraobserver and interobserver variation to be able to assess how meaningful the groupings are. The differences between histological classifications are not fundamental in the sense that they recognise different histological groups, but rather interpretive in that they make different decisions about where such groups should be fitted into the classification or where to draw the line between related or similar groups. Perhaps the final decision on which classification is to be used should be based empirically on which classification provides the most reproducible results in use for histological diagnosis when large or small amounts of tissue are available and for cytological diagnosis.
The inadequacies of pathological classification and its application are recognised by pathologists and they should be recognised and understood by clinicians. The responsibility for improving
